With the recent explosion of healthcare data in the U.S. as well as the announcement of several well-publicized partnerships between manufacturers and providers or payers, the emergence of data collaborations is currently one of the hottest trends in healthcare.

It’s no secret that the pharmaceutical industry is facing a series of unprecedented challenges.  Payers are increasingly demanding that new products and treatments demonstrate both economic and clinical value, as escalating healthcare costs are no longer considered sustainable. With mounting pressure from payers as well as increased regulatory scrutiny and financial penalties tied to clinical performance, providers are also becoming much more focused on cost and outcomes – a trend that’s expected to accelerate as provider consolidation continues.